Market Overview

Morgan Stanley Sees LifePoint Hospitals as Riding Medicaid Expansion in 2014

Share:

In a report published Tuesday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT).

In the report, Morgan Stanley noted, “LPNT expects 2014 Adj. EBITDA of $560M to $590M inclusive of reform which implies growth of 4.3% to 9.9% Y/Y. Guidance compares with MS estimates of $582M and consensus of $585M. Adj. EPS is expected to come in between $2.38 to $2.78 per share, excluding a newly authorized $150M repurchase program set to begin post completion of the current program. We note MS estimate of $2.71 assumes $75M of the new program is completed in 2014.”

LifePoint Hospitals closed on Friday at $48.46.

Latest Ratings for LPNT

DateFirmActionFromTo
Jul 2018MaintainsNeutralNeutral
Jul 2018MaintainsMarket PerformMarket Perform
Jul 2018DowngradesOutperformNeutral

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (LPNT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
GMLPReiterates10.0
JWNReiterates29.0
DSGXInitiates Coverage On43.0
ZMAssumes115.0
LOGMAssumes77.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Top #PreMarket Losers

UPDATE: Morgan Stanley Upgrades Forest Laboratories Ahead of Further Financial Upside